Biopharmaceutics delves into the complex connection between the physical and chemical attributes of drugs and their optimal dosages, influencing drug action. It entails evaluating how a drug's physicochemical features and its formulation affect bioavailability and therapeutic effects. This field scrutinizes the intricate interplay among a drug's properties, its biological fate post-administration, and the consequent pharmacological actions.
Biopharmaceutics places significant emphasis on comprehending critical physicochemical properties, playing a pivotal role in optimizing drug formulations for heightened efficacy and ensuring successful therapeutic outcomes. It investigates the dynamic interplay between a drug's properties, its biological fate after administration, and the resulting pharmacological actions.
By thoroughly assessing these factors, biopharmaceutics aims to enhance our understanding of drug behavior in the body, ultimately contributing to the development of more effective and tailored drug formulations. This discipline serves as a cornerstone for pharmaceutical advancements, guiding the design and optimization of drug delivery systems to maximize therapeutic benefits. Biopharmaceutics plays a crucial role in bridging the gap between drug development and clinical application, fostering advancements in pharmacotherapy for improved patient outcomes.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico